Kim SH - Search Results

1

Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.

Lee J, Shin YJ, Lee K, Cho HJ, Sa JK, Lee SY, Kim SH, Lee J, Yoon Y, Nam DH. Lee J, et al. Among authors: kim sh. Cancer Res Treat. 2018 Jul;50(3):1009-1022. doi: 10.4143/crt.2017.315. Epub 2017 Nov 10. Cancer Res Treat. 2018. PMID: 29129044 Free PMC article.

2

Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.

Wang LH, Kim SH, Lee JH, Choi YL, Kim YC, Park TS, Hong YC, Wu CF, Shin YK. Wang LH, et al. Among authors: kim sh, kim yc. Clin Cancer Res. 2007 Jan 1;13(1):102-10. doi: 10.1158/1078-0432.CCR-06-1467. Clin Cancer Res. 2007. PMID: 17200344

3

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.

Sung CO, Kim SC, Karnan S, Karube K, Shin HJ, Nam DH, Suh YL, Kim SH, Kim JY, Kim SJ, Kim WS, Seto M, Ko YH. Sung CO, et al. Among authors: kim jy, kim sc, kim sh, kim sj, kim ws. Blood. 2011 Jan 27;117(4):1291-300. doi: 10.1182/blood-2010-07-297861. Epub 2010 Nov 18. Blood. 2011. PMID: 21088137 Free article.

4

The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.

Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK. Jung HS, et al. Among authors: kim jk, kim sh, kim yd. Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8. Int J Cancer. 2012. PMID: 21630254

5

Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.

Tae CH, Ryu KJ, Kim SH, Kim HC, Chun HK, Min BH, Chang DK, Rhee PL, Kim JJ, Rhee JC, Kim YH. Tae CH, et al. Among authors: kim yh, kim jj, kim sh, kim hc. BMC Cancer. 2013 Mar 22;13:142. doi: 10.1186/1471-2407-13-142. BMC Cancer. 2013. PMID: 23517143 Free PMC article.

6

Twist1 is essential in maintaining mesenchymal state and tumor-initiating properties in synovial sarcoma.

Lee KW, Lee NK, Ham S, Roh TY, Kim SH. Lee KW, et al. Among authors: kim sh. Cancer Lett. 2014 Feb 1;343(1):62-73. doi: 10.1016/j.canlet.2013.09.013. Epub 2013 Sep 16. Cancer Lett. 2014. PMID: 24051309

7

CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.

Lee KW, Sung CO, Kim JH, Kang M, Yoo HY, Kim HH, Um SH, Kim SH. Lee KW, et al. Among authors: kim hh, kim sh, kim jh. Int J Cancer. 2015 Jan 15;136(2):310-21. doi: 10.1002/ijc.29006. Epub 2014 Jun 26. Int J Cancer. 2015. PMID: 24895167

8

GAGE12 mediates human gastric carcinoma growth and metastasis.

Lee EK, Song KA, Chae JH, Kim KM, Kim SH, Kang MS. Lee EK, et al. Among authors: kim km, kim sh. Int J Cancer. 2015 May 15;136(10):2284-92. doi: 10.1002/ijc.29286. Epub 2014 Nov 6. Int J Cancer. 2015. PMID: 25346337

9

Twist1 is a key regulator of cancer-associated fibroblasts.

Lee KW, Yeo SY, Sung CO, Kim SH. Lee KW, et al. Among authors: kim sh. Cancer Res. 2015 Jan 1;75(1):73-85. doi: 10.1158/0008-5472.CAN-14-0350. Epub 2014 Nov 3. Cancer Res. 2015. PMID: 25368021

10

Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain.

Park H, Kim D, Kim E, Sa JK, Lee HW, Yu S, Oh J, Kim SH, Yoon Y, Nam DH. Park H, et al. Among authors: kim e, kim d, kim sh. Int J Mol Sci. 2017 Sep 13;18(9):1968. doi: 10.3390/ijms18091968. Int J Mol Sci. 2017. PMID: 28902178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,089 results

Search Page

Filters